chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash, Rash macular
Clinical narrative: itchy, chickenpox type rash on back, trunk, armpit, and base of neck; This is a spontaneous report from a contactable consumer (patient herself). A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: en9581), via an unspecified route of administration on 03Feb2021 as dose number unknown, single for COVID-19 immunization. Patient medical history included asthma. It was reported that, she had drug allergies to Amoxicillin and Vicodin. She was not pregnant at the time of vaccination. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The other medications that she received within 2 weeks of vaccination was Vitamins. She was not diagnosed with COVID-19, prior to vaccination and tested for COVID-19 since the vaccination. On 05Feb2021, the patient experienced itchy, chickenpox type rash on back, trunk, armpit, and base of neck. It was stated that, as the result of AE, she had visited physician's office and received the treatment for itchy, chickenpox type rash on back, trunk, armpit, and base of neck (rash pruritic): antihistamines. Seriousness of the events was considered as non-serious. The outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash pruritic
Clinical narrative: itchy, chickenpox type rash on back, trunk, armpit, and base of neck; This is a spontaneous report from a contactable consumer (patient herself). A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: en9581), via an unspecified route of administration on 03Feb2021 as dose number unknown, single for COVID-19 immunization. Patient medical history included asthma. It was reported that, she had drug allergies to Amoxicillin and Vicodin. She was not pregnant at the time of vaccination. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The other medications that she received within 2 weeks of vaccination was Vitamins. She was not diagnosed with COVID-19, prior to vaccination and tested for COVID-19 since the vaccination. On 05Feb2021, the patient experienced itchy, chickenpox type rash on back, trunk, armpit, and base of neck. It was stated that, as the result of AE, she had visited physician's office and received the treatment for itchy, chickenpox type rash on back, trunk, armpit, and base of neck (rash pruritic): antihistamines. Seriousness of the events was considered as non-serious. The outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Lacrimation increased, Pain, Pyrexia, Sneezing
Clinical narrative: This is a spontaneous report from a Pfizer Sponsored Program. A contactable male consumer or other non hcp reported. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, (Batch/Lot number was not reported)), dose 1 via an unspecified route of administration on an unspecified date as dose 1 single for COVID-19 immunisation. The patient's medical history concomitant medications were not reported. The patient experienced mild fever on an unspecified date. The outcome of the event was unknown.  Information about lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Suspected COVID-19
Clinical narrative: This is a spontaneous report from a Pfizer Sponsored Program. A contactable male consumer or other non hcp reported. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, (Batch/Lot number was not reported)), dose 1 via an unspecified route of administration on an unspecified date as dose 1 single for COVID-19 immunisation. The patient's medical history concomitant medications were not reported. The patient experienced mild fever on an unspecified date. The outcome of the event was unknown.  Information about lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: This is a spontaneous report from a Pfizer Sponsored Program. A contactable male consumer or other non hcp reported. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, (Batch/Lot number was not reported)), dose 1 via an unspecified route of administration on an unspecified date as dose 1 single for COVID-19 immunisation. The patient's medical history concomitant medications were not reported. The patient experienced mild fever on an unspecified date. The outcome of the event was unknown.  Information about lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia
Clinical narrative: numbness in my face (both sides); This is a spontaneous report from a contactable Consumer (patient). A 50-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6203), via an unspecified route on 02Mar2021 at 15:15 (at the age of 50-year-old) as dose 1, single in the left arm for COVID-19 immunization. The patient's medical history included known allergies to Amoxicillin, Penicillin, Sulfa drugs, Clindamycin, Ciprofloxacin. The patient's concomitant medications included ethinylestradiol, norgestrel (CRYSELLE-28), melatonin (VITAFUSION SLEEPWELL) from an unknown date and ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Mar2021 at 15:45, the patient experienced roughly 25 minutes after receiving the vaccine numbness in her face (both sides). It lasted 1.5-2 hours. The patient did not received treatment for event. The outcome for the event was recovered on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chest pain, Dizziness, Headache, Myalgia
Clinical narrative: chest pain; dizziness; joint and muscle pain; joint and muscle pain; severe headache & tinitius; severe headache & tinitius; EXTREME FACIAL SWELLING; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 65-year-old non-pregnant female patient received second dose of BNT162B2 (COMIRNATY, solution for injection, Lot number: EN6200), via an unspecified route of administration, in Arm Right on 13Feb2021 09:30 (age at the vaccination 65-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included allergies to medications, mild arthritis, allergy; tree Nuts, Mango, Shrimp, allergy: cats. Concomitant medications included cyanocobalamin (B12), ascorbic acid (C), celecoxib (CELEBREX) taken for adenomatous polyposis coli, colecalciferol (D3), estrogens conjugated (PREMARIN) and levothyroxine sodium (LEVOTHYROXINE). The patient previously took penicillin [benzylpenicillin] and experienced allergies. The patient historical vaccine includes first dose of COVID vaccine (COMIRNATY, solution for injection, Lot number: EN9262) on 23Jan2021 09:30 AM in right arm for covid-19 immunisation. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. After second dose patient experienced chest pain on 14Feb2021 04:30 AM, and dizziness, joint pain, muscle pain, severe headache, tinitius, and extreme facial swelling on an unspecified date in 2021. Therapeutic measures were taken as a result for all events. The outcome of the events was recovering.  Follow-up (31May2021): Follow-up attempts completed. No further information expected.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling face
Clinical narrative: chest pain; dizziness; joint and muscle pain; joint and muscle pain; severe headache & tinitius; severe headache & tinitius; EXTREME FACIAL SWELLING; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 65-year-old non-pregnant female patient received second dose of BNT162B2 (COMIRNATY, solution for injection, Lot number: EN6200), via an unspecified route of administration, in Arm Right on 13Feb2021 09:30 (age at the vaccination 65-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included allergies to medications, mild arthritis, allergy; tree Nuts, Mango, Shrimp, allergy: cats. Concomitant medications included cyanocobalamin (B12), ascorbic acid (C), celecoxib (CELEBREX) taken for adenomatous polyposis coli, colecalciferol (D3), estrogens conjugated (PREMARIN) and levothyroxine sodium (LEVOTHYROXINE). The patient previously took penicillin [benzylpenicillin] and experienced allergies. The patient historical vaccine includes first dose of COVID vaccine (COMIRNATY, solution for injection, Lot number: EN9262) on 23Jan2021 09:30 AM in right arm for covid-19 immunisation. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. After second dose patient experienced chest pain on 14Feb2021 04:30 AM, and dizziness, joint pain, muscle pain, severe headache, tinitius, and extreme facial swelling on an unspecified date in 2021. Therapeutic measures were taken as a result for all events. The outcome of the events was recovering.  Follow-up (31May2021): Follow-up attempts completed. No further information expected.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling face, Tinnitus
Clinical narrative: chest pain; dizziness; joint and muscle pain; joint and muscle pain; severe headache & tinitius; severe headache & tinitius; EXTREME FACIAL SWELLING; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 65-year-old non-pregnant female patient received second dose of BNT162B2 (COMIRNATY, solution for injection, Lot number: EN6200), via an unspecified route of administration, in Arm Right on 13Feb2021 09:30 (age at the vaccination 65-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included allergies to medications, mild arthritis, allergy; tree Nuts, Mango, Shrimp, allergy: cats. Concomitant medications included cyanocobalamin (B12), ascorbic acid (C), celecoxib (CELEBREX) taken for adenomatous polyposis coli, colecalciferol (D3), estrogens conjugated (PREMARIN) and levothyroxine sodium (LEVOTHYROXINE). The patient previously took penicillin [benzylpenicillin] and experienced allergies. The patient historical vaccine includes first dose of COVID vaccine (COMIRNATY, solution for injection, Lot number: EN9262) on 23Jan2021 09:30 AM in right arm for covid-19 immunisation. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. After second dose patient experienced chest pain on 14Feb2021 04:30 AM, and dizziness, joint pain, muscle pain, severe headache, tinitius, and extreme facial swelling on an unspecified date in 2021. Therapeutic measures were taken as a result for all events. The outcome of the events was recovering.  Follow-up (31May2021): Follow-up attempts completed. No further information expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: I was dizzy; Felt like vertigo; had trouble moving around for about 2 hours; my face went numb included my tongue,but only exterior of my face(didn't include my actual lips, but outer muscles around my lips); my face went numb included my tongue, but only exterior of my face(didn't include my actual lips, but outer muscles around my lips); This is a spontaneous report from a Contactable consumer. This 37-year female consumer reported for herself that:  A 37-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL9261), via an unspecified route of administration, administered in Arm Left on 03Mar2021 12:15 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included known allergy: Penicillin, mild asthma, asthma. Patient received daily vitamin in two weeks. Patient had not received any other vaccines within 4 weeks. No prior vaccination. Post vaccination, the patient was not tested for COVID-19. The patient previously took amoxicillin and experienced drug hypersensitivity. On 03Mar2021 12:50, the patient experienced my face went numb included my tongue, but only exterior of my face (didn't include my actual lips, but outer muscles around my lips). On 04Mar2021 07:00, i was dizzy, felt like vertigo, had trouble moving around for about 2 hours. Facility type vaccination was Pharmacy or Drug Store. No treatment received for events. The clinical outcome of events was recovered on unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyskinesia, Hypoaesthesia, Hypoaesthesia oral, Vertigo
Clinical narrative: I was dizzy; Felt like vertigo; had trouble moving around for about 2 hours; my face went numb included my tongue,but only exterior of my face(didn't include my actual lips, but outer muscles around my lips); my face went numb included my tongue, but only exterior of my face(didn't include my actual lips, but outer muscles around my lips); This is a spontaneous report from a Contactable consumer. This 37-year female consumer reported for herself that:  A 37-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL9261), via an unspecified route of administration, administered in Arm Left on 03Mar2021 12:15 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included known allergy: Penicillin, mild asthma, asthma. Patient received daily vitamin in two weeks. Patient had not received any other vaccines within 4 weeks. No prior vaccination. Post vaccination, the patient was not tested for COVID-19. The patient previously took amoxicillin and experienced drug hypersensitivity. On 03Mar2021 12:50, the patient experienced my face went numb included my tongue, but only exterior of my face (didn't include my actual lips, but outer muscles around my lips). On 04Mar2021 07:00, i was dizzy, felt like vertigo, had trouble moving around for about 2 hours. Facility type vaccination was Pharmacy or Drug Store. No treatment received for events. The clinical outcome of events was recovered on unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Increased blood pressure, heart rate; Increased blood pressure, heart rate; Redness on both arms, neck, and face; Numbness in left arm, mouth, neck, face; Product=COVID 19, brand=Moderna, dose number=1/ Product=COVID 19, brand=Pfizer; This is a spontaneous report from a contactable consumer, the patient. A 42-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9266), via an unspecified route of administration, administered in left arm on 05Mar2021 at 13:15 (at the age of 42-years-old) as dose 2 (initial pfizer dose), single for COVID-19 immunization; and also received covid-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE; Lot Number: 007M20A), via an unspecified route of administration, administered in right arm on 01Feb2021 at 15:30 (at the age of 42-years-old), as dose 1, single for COVID-19 immunization. Facility type Vaccine was Public Health Clinic/Veterans. Medical history included high cholesterol and PCOS (Polycystic ovarian syndrome); both from an unknown date and unknown if ongoing. Concomitant medications included metformin, spironolactone (SPIRONOLACTON) and rosuvastatin: all taken for an unspecified indication, start and stop dates were not reported. The patient had known allergies to Codeine. Patient did not receive any other vaccine in four weeks. Patient did not have Covid prior vaccination. Patient was not tested for Covid post vaccination. On 05Mar2021 at 13:30, patient experienced redness on both arms, neck, and face, numbness in left arm, mouth, neck, face and increased blood pressure, heart rate. The patient underwent lab tests and procedures which included heart rate and blood pressure both of which was increased on 05Mar2021. The events did not result in emergency room/ physician office visit. The outcome of the events was recovered on an unspecified date in 2021.  No follow up attempts are possible. No Further information is excepted.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Erythema, Heart rate, Heart rate increased
Clinical narrative: Increased blood pressure, heart rate; Increased blood pressure, heart rate; Redness on both arms, neck, and face; Numbness in left arm, mouth, neck, face; Product=COVID 19, brand=Moderna, dose number=1/ Product=COVID 19, brand=Pfizer; This is a spontaneous report from a contactable consumer, the patient. A 42-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9266), via an unspecified route of administration, administered in left arm on 05Mar2021 at 13:15 (at the age of 42-years-old) as dose 2 (initial pfizer dose), single for COVID-19 immunization; and also received covid-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE; Lot Number: 007M20A), via an unspecified route of administration, administered in right arm on 01Feb2021 at 15:30 (at the age of 42-years-old), as dose 1, single for COVID-19 immunization. Facility type Vaccine was Public Health Clinic/Veterans. Medical history included high cholesterol and PCOS (Polycystic ovarian syndrome); both from an unknown date and unknown if ongoing. Concomitant medications included metformin, spironolactone (SPIRONOLACTON) and rosuvastatin: all taken for an unspecified indication, start and stop dates were not reported. The patient had known allergies to Codeine. Patient did not receive any other vaccine in four weeks. Patient did not have Covid prior vaccination. Patient was not tested for Covid post vaccination. On 05Mar2021 at 13:30, patient experienced redness on both arms, neck, and face, numbness in left arm, mouth, neck, face and increased blood pressure, heart rate. The patient underwent lab tests and procedures which included heart rate and blood pressure both of which was increased on 05Mar2021. The events did not result in emergency room/ physician office visit. The outcome of the events was recovered on an unspecified date in 2021.  No follow up attempts are possible. No Further information is excepted.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Wrong product administered
Clinical narrative: Increased blood pressure, heart rate; Increased blood pressure, heart rate; Redness on both arms, neck, and face; Numbness in left arm, mouth, neck, face; Product=COVID 19, brand=Moderna, dose number=1/ Product=COVID 19, brand=Pfizer; This is a spontaneous report from a contactable consumer, the patient. A 42-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9266), via an unspecified route of administration, administered in left arm on 05Mar2021 at 13:15 (at the age of 42-years-old) as dose 2 (initial pfizer dose), single for COVID-19 immunization; and also received covid-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE; Lot Number: 007M20A), via an unspecified route of administration, administered in right arm on 01Feb2021 at 15:30 (at the age of 42-years-old), as dose 1, single for COVID-19 immunization. Facility type Vaccine was Public Health Clinic/Veterans. Medical history included high cholesterol and PCOS (Polycystic ovarian syndrome); both from an unknown date and unknown if ongoing. Concomitant medications included metformin, spironolactone (SPIRONOLACTON) and rosuvastatin: all taken for an unspecified indication, start and stop dates were not reported. The patient had known allergies to Codeine. Patient did not receive any other vaccine in four weeks. Patient did not have Covid prior vaccination. Patient was not tested for Covid post vaccination. On 05Mar2021 at 13:30, patient experienced redness on both arms, neck, and face, numbness in left arm, mouth, neck, face and increased blood pressure, heart rate. The patient underwent lab tests and procedures which included heart rate and blood pressure both of which was increased on 05Mar2021. The events did not result in emergency room/ physician office visit. The outcome of the events was recovered on an unspecified date in 2021.  No follow up attempts are possible. No Further information is excepted.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: the hives really got bad after the shot (first dose)/hives were really bad event after; This is a spontaneous report from a contactable consumer. A 44-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 01Mar2021 at 12:15 (Batch/Lot Number: EN602) as DOSE 1, SINGLE, then via an unspecified route of administration on 24Mar2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history included hives on 26Feb2021 (reported 3 days prior to 1st dose). Concomitant medication included metformin, atorvastatin calcium, levothyroxine, taken for an unspecified indication, start and stop date were not reported. On an unspecified date, the hives really got bad after the shot (first dose). On 24Mar2021, the patient received second dose and hives were really bad event after. The patient was out of hives for almost 4 years and was taking Xolair specialty shot (in fact was on the path to discontinue that) but now the patient has to keep on taking Xolair unless hives get controlled. The outcome of the event was not recovered.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: my ears have been ringing/have never had tinnitus before; This is a spontaneous report from a contactable consumer or other non hcp (patient).A male patient of an unspecified age received bnt162b2 (BNT162B2, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.The patient experienced have never had tinnitus before and my ears have been ringing on an unspecified date. The clinical course as follows as I received my first dose on match 1st of BioNTech vaccine my ears have been ringing since 3/1 m. I need to know what I should do since my 2nd dose is this week. I have never had tinnitus before and found others w the same side effect since they received their Pfizer vaccine. The outcome of event was unknown.  No follow-up attempts are possible, Information about lot/batch cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Body temperature, Headache, Pyrexia
Clinical narrative: fever; Headache; joint pain; This is a spontaneous report from a contactable other hcp. A female patient of an unspecified age received second dose of BNT162B2 (COMIRNATY, formulation: Solution for injection, Batch/lot number: EL3249) via an intramuscular route of administration on 02Feb2021 10:30 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had historical vaccine of BNT162B2 (COMIRNATY, formulation: Solution for injection, Batch/lot number: EK9231) via an intramuscular route of administration on 12Jan2021 10:30 as single dose for covid-19 immunisation. The patient received any other vaccines within 4 weeks prior to the COVID vaccine reported as none. On 02Feb2021 20:00 the patient experienced fever, headache, joint pain. The patient did not receive any treatment for the adverse events. The clinical outcome of the events was recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Headache, Pyrexia
Clinical narrative: fever; Headache; joint pain; This is a spontaneous report from a contactable other hcp. A female patient of an unspecified age received second dose of BNT162B2 (COMIRNATY, formulation: Solution for injection, Batch/lot number: EL3249) via an intramuscular route of administration on 02Feb2021 10:30 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had historical vaccine of BNT162B2 (COMIRNATY, formulation: Solution for injection, Batch/lot number: EK9231) via an intramuscular route of administration on 12Jan2021 10:30 as single dose for covid-19 immunisation. The patient received any other vaccines within 4 weeks prior to the COVID vaccine reported as none. On 02Feb2021 20:00 the patient experienced fever, headache, joint pain. The patient did not receive any treatment for the adverse events. The clinical outcome of the events was recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: my face on right side was numb; tasted something in my mouth like metal; This is a spontaneous report from a contactable consumer (Patient). A 58-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6203), via an unspecified route of administration on 10Mar2021 at 12:00 (at the age of 58-year-old), as dose 1, single in right arm for COVID-19 immunization at Pharmacy/drug store. The patient's medical history included hypothyroidism. Patient had no known allergies. Concomitant medications in two weeks included levothyroxine sodium (LEVOTHYROXIN); and bupropion hydrochloride (WELLBUTRIN), all taken for an unspecified indication, start and stop dates were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Mar2021 at 12:15, 15 minutes after the first dose of vaccine, the patient's face on right side was numb, tasted something in her mouth like metal. Patient was fine for the first 15 minutes after vaccination. Once she was in the car to leave, she immediately tasted something in her mouth like metal and then her face on right side was numb, near right ear, right cheek, jawline, and tongue. There was no swelling. Sensation subsided by next morning. Patient felt like there was still be some numbness but very mild. Patient was hesitant to take second dose. No treatment was received for the events. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The clinical outcome of both the events was reported as unknown.  No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Hypoaesthesia
Clinical narrative: my face on right side was numb; tasted something in my mouth like metal; This is a spontaneous report from a contactable consumer (Patient). A 58-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6203), via an unspecified route of administration on 10Mar2021 at 12:00 (at the age of 58-year-old), as dose 1, single in right arm for COVID-19 immunization at Pharmacy/drug store. The patient's medical history included hypothyroidism. Patient had no known allergies. Concomitant medications in two weeks included levothyroxine sodium (LEVOTHYROXIN); and bupropion hydrochloride (WELLBUTRIN), all taken for an unspecified indication, start and stop dates were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Mar2021 at 12:15, 15 minutes after the first dose of vaccine, the patient's face on right side was numb, tasted something in her mouth like metal. Patient was fine for the first 15 minutes after vaccination. Once she was in the car to leave, she immediately tasted something in her mouth like metal and then her face on right side was numb, near right ear, right cheek, jawline, and tongue. There was no swelling. Sensation subsided by next morning. Patient felt like there was still be some numbness but very mild. Patient was hesitant to take second dose. No treatment was received for the events. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The clinical outcome of both the events was reported as unknown.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Joint stiffness, Neuralgia, Pain in extremity, Throat irritation
Clinical narrative: Extreme itching in mouth and throat 6 hours after injection; numbness; nerve pain in left ring finger then pinky and around arm pit and top of left wrist; Stiffness in jaw; This is a spontaneous report from a contactable consumer. This 59-year-old female consumer reported.   A 59-year-old non-pregnant female patient (not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 14Mar2021 14:45 (age at the time of vaccination was 59-year-old) as dose 1, single for COVID-19 immunization. Medical history included Tree nut allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccine prior to COVID-19 Vaccine. The patient did not receive any other medication prior to COVID-19 Vaccine in 2 weeks. The patient did not test COVID-19 positive prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. It was reported that, on 14Mar2021, at 15:00, within 10 min of injection, numbness and nerve pain in left ring finger then pinky and around arm pit and top of left wrist. Stiffness in jaw. Extreme itching in mouth and throat 6 hours after injection on 14Mar2021 20:45. No treatment was received for the event. The outcome of the events wee recovered on an unspecified date on 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Musculoskeletal stiffness, Neuralgia, Oral pruritus
Clinical narrative: Extreme itching in mouth and throat 6 hours after injection; numbness; nerve pain in left ring finger then pinky and around arm pit and top of left wrist; Stiffness in jaw; This is a spontaneous report from a contactable consumer. This 59-year-old female consumer reported.   A 59-year-old non-pregnant female patient (not pregnant at the time of vaccination) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 14Mar2021 14:45 (age at the time of vaccination was 59-year-old) as dose 1, single for COVID-19 immunization. Medical history included Tree nut allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccine prior to COVID-19 Vaccine. The patient did not receive any other medication prior to COVID-19 Vaccine in 2 weeks. The patient did not test COVID-19 positive prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. It was reported that, on 14Mar2021, at 15:00, within 10 min of injection, numbness and nerve pain in left ring finger then pinky and around arm pit and top of left wrist. Stiffness in jaw. Extreme itching in mouth and throat 6 hours after injection on 14Mar2021 20:45. No treatment was received for the event. The outcome of the events wee recovered on an unspecified date on 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dysphagia, Lip pruritus, Lip swelling, Throat clearing, Throat irritation
Clinical narrative: slight headache; weak and tired; weak and tired; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 15Mar2021 (Batch/Lot Number: EN6200) (at age 65-years-old) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. When the patient received the first dose Pfizer Covid Vaccine on 15Mar2021, she had a severe reaction from it and was taken to the emergency room then discharged. The paramedics had to come to the vaccination site and give the patient mediations there. She was sick for about a week behind the first dose Pfizer Covid Vaccine with slight headache, just weak and tired as soon as the first dose was administered on 15Mar2021. She was in bed for about what seemed like a month or at least three weeks until the patient went to get the second dose of Pfizer Covid Vaccine. Outcome of the event of headache was not recovered while for the remaining events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Fatigue, Headache
Clinical narrative: slight headache; weak and tired; weak and tired; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 15Mar2021 (Batch/Lot Number: EN6200) (at age 65-years-old) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. When the patient received the first dose Pfizer Covid Vaccine on 15Mar2021, she had a severe reaction from it and was taken to the emergency room then discharged. The paramedics had to come to the vaccination site and give the patient mediations there. She was sick for about a week behind the first dose Pfizer Covid Vaccine with slight headache, just weak and tired as soon as the first dose was administered on 15Mar2021. She was in bed for about what seemed like a month or at least three weeks until the patient went to get the second dose of Pfizer Covid Vaccine. Outcome of the event of headache was not recovered while for the remaining events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Pain, Pulmonary thrombosis, Thrombosis
Clinical narrative: slight headache; weak and tired; weak and tired; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 15Mar2021 (Batch/Lot Number: EN6200) (at age 65-years-old) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. When the patient received the first dose Pfizer Covid Vaccine on 15Mar2021, she had a severe reaction from it and was taken to the emergency room then discharged. The paramedics had to come to the vaccination site and give the patient mediations there. She was sick for about a week behind the first dose Pfizer Covid Vaccine with slight headache, just weak and tired as soon as the first dose was administered on 15Mar2021. She was in bed for about what seemed like a month or at least three weeks until the patient went to get the second dose of Pfizer Covid Vaccine. Outcome of the event of headache was not recovered while for the remaining events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: About one week after the first shot, I got tinnitus.  It is still with me.; This is a spontaneous report from a contactable consumer, the patient. An 81-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the left arm on 30Jan2021 at 08:30 (at the age of 81-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL 9264) via an unspecified route of administration in the left arm on 20Feb2021 at 08:30 (at the age of 81-years-old) as a single dose for COVID-19 immunisation. The patient previously took sulfa and experienced sulfonamide allergy. The patient had received other medications within 2 weeks of vaccination but was unspecified. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Feb2021 at 09:00, about one week after the first shot the patient experienced tinnitus. It was reported that the tinnitus was still with her. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events.. The clinical outcome of the event tinnitus was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Full blood count, Headache, Impaired work ability, Metabolic function test
Clinical narrative: severe dizziness; nausea; This is a spontaneous report from a contactable other health care professional. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 10Mar2021 as DOSE 1, SINGLE for COVID-19 immunization. Medical history included asthma (Note: patient have a severe asthma patient at high risk of getting the COCID-19) from an unknown date and unknown if ongoing. Concomitant medication was not reported. On 10Mar2021 and 6 hours after getting the shot, the patient experienced severe dizziness and nausea that lasted for 16 days. Patient unsure now on getting the 2nd dose. One doctor advised here not to get the 2nd dose, but the other doctor advised to get the 2nd dose. Patient was really confused right now on whether patient would take the 2nd shot or not. But patient want to be fully vaccinated and be protected. Patient wants information and guidance on getting the 2nd dose and to know the safety of getting the 2nd shot, will patient be having worse side reaction like the 1st dose and was it still okay and safe to get the 2nd dose of vaccine 5 months after the 1st shot. The outcome of the events were recovered on Mar2021.  The lot number was not provided and Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, SARS-CoV-2 test negative
Clinical narrative: severe dizziness; nausea; This is a spontaneous report from a contactable other health care professional. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 10Mar2021 as DOSE 1, SINGLE for COVID-19 immunization. Medical history included asthma (Note: patient have a severe asthma patient at high risk of getting the COCID-19) from an unknown date and unknown if ongoing. Concomitant medication was not reported. On 10Mar2021 and 6 hours after getting the shot, the patient experienced severe dizziness and nausea that lasted for 16 days. Patient unsure now on getting the 2nd dose. One doctor advised here not to get the 2nd dose, but the other doctor advised to get the 2nd dose. Patient was really confused right now on whether patient would take the 2nd shot or not. But patient want to be fully vaccinated and be protected. Patient wants information and guidance on getting the 2nd dose and to know the safety of getting the 2nd shot, will patient be having worse side reaction like the 1st dose and was it still okay and safe to get the 2nd dose of vaccine 5 months after the 1st shot. The outcome of the events were recovered on Mar2021.  The lot number was not provided and Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: severe dizziness; nausea; This is a spontaneous report from a contactable other health care professional. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 10Mar2021 as DOSE 1, SINGLE for COVID-19 immunization. Medical history included asthma (Note: patient have a severe asthma patient at high risk of getting the COCID-19) from an unknown date and unknown if ongoing. Concomitant medication was not reported. On 10Mar2021 and 6 hours after getting the shot, the patient experienced severe dizziness and nausea that lasted for 16 days. Patient unsure now on getting the 2nd dose. One doctor advised here not to get the 2nd dose, but the other doctor advised to get the 2nd dose. Patient was really confused right now on whether patient would take the 2nd shot or not. But patient want to be fully vaccinated and be protected. Patient wants information and guidance on getting the 2nd dose and to know the safety of getting the 2nd shot, will patient be having worse side reaction like the 1st dose and was it still okay and safe to get the 2nd dose of vaccine 5 months after the 1st shot. The outcome of the events were recovered on Mar2021.  The lot number was not provided and Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Illness, Laboratory test, Nausea, Pain in extremity
Clinical narrative: severe dizziness; nausea; This is a spontaneous report from a contactable other health care professional. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 10Mar2021 as DOSE 1, SINGLE for COVID-19 immunization. Medical history included asthma (Note: patient have a severe asthma patient at high risk of getting the COCID-19) from an unknown date and unknown if ongoing. Concomitant medication was not reported. On 10Mar2021 and 6 hours after getting the shot, the patient experienced severe dizziness and nausea that lasted for 16 days. Patient unsure now on getting the 2nd dose. One doctor advised here not to get the 2nd dose, but the other doctor advised to get the 2nd dose. Patient was really confused right now on whether patient would take the 2nd shot or not. But patient want to be fully vaccinated and be protected. Patient wants information and guidance on getting the 2nd dose and to know the safety of getting the 2nd shot, will patient be having worse side reaction like the 1st dose and was it still okay and safe to get the 2nd dose of vaccine 5 months after the 1st shot. The outcome of the events were recovered on Mar2021.  The lot number was not provided and Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: severe dizziness; nausea; This is a spontaneous report from a contactable other health care professional. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 10Mar2021 as DOSE 1, SINGLE for COVID-19 immunization. Medical history included asthma (Note: patient have a severe asthma patient at high risk of getting the COCID-19) from an unknown date and unknown if ongoing. Concomitant medication was not reported. On 10Mar2021 and 6 hours after getting the shot, the patient experienced severe dizziness and nausea that lasted for 16 days. Patient unsure now on getting the 2nd dose. One doctor advised here not to get the 2nd dose, but the other doctor advised to get the 2nd dose. Patient was really confused right now on whether patient would take the 2nd shot or not. But patient want to be fully vaccinated and be protected. Patient wants information and guidance on getting the 2nd dose and to know the safety of getting the 2nd shot, will patient be having worse side reaction like the 1st dose and was it still okay and safe to get the 2nd dose of vaccine 5 months after the 1st shot. The outcome of the events were recovered on Mar2021.  The lot number was not provided and Information on the lot/batch number has been requested.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased
Clinical narrative: Elevated or racing heart/ My heart rate has been jumping over 130 with Simple activities like brushing my teeth/ elevated HR 130-150s; This is a spontaneous report from a contactable other health care professional (patient). A 33-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: Unknown) via an unspecified route of administration in Arm Right on 20Mar2021 09:15 (at the age of 33 years old, unknown if patient pregnant) as dose 1, single for Covid-19 immunization. Medical history reported as none. Patient did not have allergies to medications, food, or other products. The patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. Patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with Covid-19. Since the vaccination, the patient has not been tested for Covid-19. The patient experienced elevated or racing heart/ my heart rate has been jumping over 130 with simple activities like brushing my teeth/ elevated heart rate 130-150s on 21Mar2021. Event reported as, elevated or racing heart. patient was very physically fit person with an average resting heart rate in the 50's. Patient heart rate has been jumping over 130 with simple activities like brushing her teeth. Patient was well hydrated and no fever. Elevated heart rate 130-150s. 100 resting. She was asking for a recommendation on receipt of second dose. She received her first dose 20Mar2021, and on Sunday, patient heart rate was super elevated. Her resting would not go under 100 and with any little activity, would jump up to 150. The day after was fine and she has been fine since. She is scheduled to get next dose 10Apr2021, and wants to make sure it is safe for her to get it. No treatment received for the adverse event. The patient underwent lab tests and procedures which included heart rate: resting would not go under 100 and with any little activity, would jump up to 150 on an unspecified date. Outcome of the event was resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.